CMS model to let Medicaid recipients with sickle cell access gene...

CMS model to let Medicaid recipients with sickle cell access gene...

The Centers for Medicare & Medicaid Services (CMS) has announced that 33 states, along with the District of Columbia and Puerto Rico, have agreed to participate in the Cell and Gene Therapy (CGT) Access Model, which is intended to boost access to cell and gene therapies for people with sickle cell disease (SCD) on Medicaid. Under the model, led by the CMS Innovation Center, participating states will receive guaranteed discounts and rebates from …